Assessment of Tocilizumab (Anti–Interleukin‐6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody‐Mediated Rejection and Transplant Glomerulopathy in HLA‐Sensitized Renal Allograft Recipients
J. Choi; O. Aubert; A. Vo; A. Loupy; M. Haas; D. Puliyanda; I. Kim; S. Louie; A. Kang; A. Peng; J. Kahwaji; N. Reinsmoen; M. Toyoda; S. C. Jordan
Author Information: Comprehensive Transplant Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.